Blood Collection Market Outlook:
Blood Collection Market size was over USD 6.1 billion in 2025 and is anticipated to cross USD 12.46 billion by 2035, witnessing more than 7.4% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of blood collection is assessed at USD 6.51 billion.
The primary growth driver of the blood collection market is the increasing demand for blood and related products including cryoprecipitated AHF (cryo), red cells, platelets, plasma, and granulocytes to cater to diagnostics, surgical procedures, treatment of chronic diseases, and other healthcare needs. For instance, according to the American Hospital Association, by 2030, around 170 million people in the U.S. are predicted to have at least one chronic ailment, including hypertension, diabetes, heart disease, and arthritis.
The COVID-19 pandemic significantly influenced the blood collection market by highlighting the critical need for blood and plasma for treatment and research. Furthermore, the rise in cancer cases worldwide is driving the need for advanced blood collection products. For instance, the World Health Organization (WHO) estimates that more than 35 million new cancer cases are expected to be detected by 2050; this hike is pushing the need for advanced services including diagnostics.
